1 Artiva Biotherapeutics Inc Receivables Turnover Ratio (ARTV), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Artiva Biotherapeutics Inc   (NASDAQ: ARTV)
 

Artiva Biotherapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Artiva Biotherapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 17.07, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Artiva Biotherapeutics Inc in Sep 30 2026 quarter, has decreased to 21 days, compared to 27 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector Artiva Biotherapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Artiva Biotherapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARTV Receivables Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Receivable Change -73.42 % 370 % - -54.11 % -88.73 %
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) 17.07 13.62 22.2 9.53 -
ARTV's Total Ranking # # # # #
Accounts Receivable average collection period days 21 27 16 38 -
Seq. Receivable Change -85.11 % - - -15.19 % 163.33 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





ARTV Company Profile • Back to ARTV Efficiency Comparisons • Compare ARTV Receivables Turnover Ratio to its Competitors

Financial Statements
Artiva Biotherapeutics Inc 's Accounts Receivable $ 0 Millions Visit ARTV's Balance sheet
Artiva Biotherapeutics Inc 's Sales TTM $ 1 Millions Visit ARTV's Income Statement
Sources of ARTV's Revenues Visit ARTV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARTV's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARTV's Growth Rates ARTV's Roa ARTV's Inventory Turnover Ratio ARTV's Dividend Comparisons
ARTV's Profitability Ratios ARTV's Roi ARTV's Asset Turnover Ratio ARTV's Dividend Growth
ARTV's Valuation Ratios ARTV's Roe ARTV's Financial Strength Ratios ARTV's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Assembly Biosciences Inc   94.75 $ 67.012  Millions$ 0.707  Millions
Metagenomi Therapeutics Inc   92.93 $ 7.086  Millions$ 0.076  Millions
Lifevantage Corp  72.32 $ 171.248  Millions$ 2.368  Millions
Nurix Therapeutics Inc   70.19 $ 701.936  Millions$ 10.000  Millions
Humacyte Inc   64.89 $ 32.703  Millions$ 0.504  Millions
National Vision Holdings Inc   46.43 $ 2,056.629  Millions$ 44.298  Millions
Kiniksa Pharmaceuticals International Plc  40.65 $ 945.963  Millions$ 23.272  Millions
Innovage Holding Corp   34.59 $ 1,018.359  Millions$ 29.443  Millions
Fortrea Holdings Inc   29.58 $ 2,666.700  Millions$ 90.150  Millions
Sonida Senior Living Inc   27.65 $ 638.130  Millions$ 23.076  Millions
Wave Life Sciences Ltd   24.65 $ 87.296  Millions$ 3.541  Millions
Lenz Therapeutics Inc   24.39 $ 12.359  Millions$ 0.507  Millions
Marpai Inc  20.07 $ 17.022  Millions$ 0.848  Millions
Arvinas Inc   20.06 $ 275.300  Millions$ 13.725  Millions
U S Physical Therapy Inc  18.16 $ 837.629  Millions$ 46.137  Millions
Alpha Pro Tech Ltd   17.54 $ 64.940  Millions$ 3.702  Millions
Longeveron Inc   15.48 $ 1.165  Millions$ 0.075  Millions
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Lifestance Health Group Inc   14.89 $ 1,676.889  Millions$ 112.631  Millions
Amneal Pharmaceuticals Inc   14.24 $ 3,196.184  Millions$ 224.488  Millions
Lifemd Inc   13.58 $ 148.224  Millions$ 10.917  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Precipio inc   13.38 $ 27.762  Millions$ 2.075  Millions
Volitionrx Limited  13.38 $ 3.445  Millions$ 0.258  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Gossamer Bio Inc   11.37 $ 78.423  Millions$ 6.896  Millions
Lineage Cell Therapeutics Inc   11.35 $ 10.836  Millions$ 0.955  Millions

Date modified: 2026-11-11T18:29:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.